10.3 C
London
Sunday, February 23, 2025
HomeMarketsEurope Markets

Europe Markets

spot_img

Levodopa/Carbidopa/Entacapone Orion | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Levodopa/Carbidopa/Entacapone Orion. It explains how the Committee for Medicinal Products for...

Lytenava | European Medicines Agency (EMA)

OverviewLytenava is a medicine used to treat adults with the ‘wet’ form of age-related macular degeneration (AMD), a disease that affects the central...

Tyruko | European Medicines Agency (EMA)

OverviewTyruko is a medicine used in adults to treat highly active multiple sclerosis (MS) that is rapidly getting worse or that is not...

Imvanex | European Medicines Agency (EMA)

OverviewImvanex is a vaccine used to protect against smallpox in adults and adolescents aged 12 years and older.Smallpox was officially declared eradicated in...

Tadalafil Mylan | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Tadalafil Mylan. It explains how the Agency assessed the medicine to...

Paxlovid | European Medicines Agency (EMA)

OverviewPaxlovid is a medicine used for treating COVID-19 in adults who do not require supplemental oxygen and who are at increased risk of...

Izba | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Izba. It explains how the Agency assessed the medicine to recommend...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img